Document is current
Any future updates will be listed below
-
Authors
Snoeijink, Tess J. https://orcid.org/0000-0003-4403-7916
van den Brekel, Anne
van der Hoek, Jan L.
Greve, Jaap G. M.
Remco Liefers, H.
Boswinkel, Milou
Ruiter, Simon J. S.
Roosen, Joey
Jebbink, Erik Groot
Nijsen, J. Frank W.
-
Funding
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (18427)
- License Information
-
More Information
Article History
Received: 20 February 2025
Accepted: 25 June 2025
First Online: 6 August 2025
Declarations
:
: This is not applicable, considering that porcine livers were obtained from a local slaughterhouse. The procurement process did not interfere with the standard abattoir protocol and was in accordance with the Dutch Food Safety Authority guidelines.
: The procurement process did not interfere with the standard abattoir protocol and was in accordance with the Dutch Food Safety Authority guidelines.
: FN is the co-founder of Quirem Medical, which was acquired by Terumo Europe NV in July 2020. Nijsen has a scientific advisory role and is entitled to certain milestone payments from Terumo, which are related to Quirem’s financial, operational and regulatory performance in the future. Furthermore, Nijsen is the inventor of the patents related to radioactive microspheres that are assigned to University Medical Centre Utrecht Holding BV, Quirem Medical or BASF Corp. The activities of FN within Quirem Medical are approved and supported by the Board of Directors of the Radboudumc. The other authors declare that they have no conflict of interest.
